Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-059592
Filing Date
2017-11-07
Accepted
2017-11-07 16:00:46
Documents
1
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6520
  Complete submission text file 0001209191-17-059592.txt   8646
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Reporting) CIK: 0000944809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 171183309
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (858) 909-0749
Sevion Therapeutics, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 8731 Services-Commercial Physical & Biological Research